Aisling Capital as of Sept. 30, 2016
Portfolio Holdings for Aisling Capital
Aisling Capital holds 20 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 21.7 | $106M | 4.0M | 26.18 | |
| Zeltiq Aesthetics | 13.0 | $63M | 1.6M | 39.22 | |
| Cynapsus Therapeutics | 9.3 | $45M | 1.1M | 40.22 | |
| Aimmune Therapeutics | 9.2 | $45M | 3.0M | 15.00 | |
| Viewray (VRAYQ) | 7.0 | $34M | 7.5M | 4.52 | |
| Versartis | 6.4 | $31M | 2.5M | 12.25 | |
| Cempra | 6.0 | $29M | 1.2M | 24.20 | |
| Adma Biologics (ADMA) | 5.4 | $26M | 3.6M | 7.25 | |
| Esperion Therapeutics (ESPR) | 4.7 | $23M | 1.6M | 13.85 | |
| T2 Biosystems | 4.2 | $21M | 2.8M | 7.24 | |
| Agile Therapeutics | 3.3 | $16M | 2.3M | 6.98 | |
| Transenterix | 2.9 | $14M | 8.3M | 1.69 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 2.4 | $12M | 1.0M | 11.45 | |
| Syros Pharmaceuticals | 1.4 | $7.1M | 509k | 13.87 | |
| Paratek Pharmaceuticals | 1.3 | $6.3M | 483k | 13.01 | |
| Intersect Ent | 0.8 | $3.9M | 249k | 15.84 | |
| Chimerix (CMRX) | 0.5 | $2.6M | 473k | 5.54 | |
| Pernix Therapeutics Holdings | 0.3 | $1.2M | 2.0M | 0.62 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $675k | 2.5M | 0.27 | |
| Lombard Med (EVARF) | 0.1 | $417k | 443k | 0.94 |
